MYR GMBH

myr-gmbh-logo

MYR Pharmaceuticals is focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D virus infections. MYRโ€™s lead compound bulevirtide (Myrcludex), a first-in-class entry inhibitor for the treatment of chronic hepatitis B and D infections, progresses into a phase III clinical study for the indication of chronic HDV infection. The drug candidate has received Orphan Drug Designations for the treatment of HDV infection from the European Medicine... s Agency (EMA) and from the U.S. Food & Drug Administration (FDA). In addition, the EMA has granted PRIority MEdicines (PRIME) scheme eligibility. In parallel the FDA has granted Breakthrough Therapy designation. The British Medicines and Healthcare products Regulatory Agency (MHRA) has recently issued the Promising Innovative Medicine (PIM) designation for MYRโ€™s lead compound Bulevirtide. In addition to hepatitis, bulevirtide has a potential for the treatment of a variety of inflammatory and metabolic diseases via additional pharmacological effects of NTCP inhibition. MYR Pharmaceuticals and its collaborators have obtained encouraging preclinical data that support further development of bulevirtide to treat dyslipidemia, nonalcoholic steatohepatitis (NASH), and primary biliary cholangitis (PBC). A Phase 1 clinical trial for dyslipidemia has been initiated. MYR Pharmaceuticals is headquartered in Bad Homburg (Germany). The company started its operations in 2011 and has raised more than EUR 30 million from a number of venture capital investors - including the German High-Tech Grรผnderfonds - and private investors. The technology was originally developed at the University of Heidelberg (Germany) by Prof. Dr. Stephan Urban and INSERM (France) by Prof. Dr. Phillipe Gripon and represents one the most clinically advanced novel approaches for the treatment of hepatitis B and D.

#SimilarOrganizations #Website #More

MYR GMBH

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2011-01-01

Address:
Bad Homburg, Hessen, Germany

Country:
Germany

Website Url:
http://www.myr-pharma.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network


Similar Organizations

arlabion-logo

Arlabion

Arlabion is an agri-tech company developing a novel seed treatment to protect crops against fungal infection.

autodisplay-logo

Autodisplay

A biotechnology company commercializing its proprietary expression platform for the display of heterologous proteins or peptide.

biomedal-logo

Biomedal

Biomedal is a biotech company developing and commercialising technologies, services and products for research, bioindustry and diagnostics.

biosearch-life-logo

Biosearch Life

e is a biotechnology company that develops and manufactures products through the innovation of natural ingredients.

biotrem-logo

Biotrem

Biotrem is a technology company developing an innovative production process of bio-based tableware and packaging.

cardiola-logo

Cardiola

Cardiola is a biotechnology company developing therapeutic systems for the treatment of chronic heart failure.

cel-sci-logo

CEL-SCI

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

excaliard-pharmaceuticals-logo

Excaliard Pharmaceuticals

Excaliard is a biotechnology company developing antisense drugs for the local treatment of scarring and other fibrotic diseases.

godx-logo

GoDx

GoDx is a biotechnology research center, developing a simple diagnostic test for the detection of infectious pathogens.

kiro-robotics-logo

Kiro Robotics

Kiro Robotics is a technology company that specializes in the automation of machinery for the hospital sector.

lactobio-logo

Lactobio

Lactobio is a probiotic and microbiome company developing cosmeceuticals, dietary supplements, and live biotherapeutic products.

mrc-holland-logo

MRC-Holland

MRC Holland is a biotechnology company specialized in the production of assays for gene copy number and gene variant detection.

syntaxin-logo

Syntaxin

Syntaxin engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine diseases.

not_available_image

Xiomateria

Xiomateria has develops biomaterials that assist in the treatment of diseases and infections.

Official Site Inspections

http://www.myr-pharma.com

Unable to get host informations!!!

Loading ...

More informations about "MYR GmbH" on Search Engine